Global Novel Drug Delivery Systems (NDDS) Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2015 to 2022

  • ID: 4313391
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • 3M Company
  • Amgen Inc.
  • Bayer AG
  • Celgene Corporation
  • Genzyme Corporation
  • Johnson & Johnson
  • MORE
Global Novel Drug Delivery Systems (NDDS) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022, the Novel Drug Delivery Systems (NDDS) market was valued at USD 165.4 Bn and is expected to reach USD 202.5 Bn by 2022, expanding at a CAGR of 2.7% from 2016 to 2022.

Market Insights
The novel drug delivery system (NDDS) provides a therapeutic amount of drug to the specific site in the body to accomplish promptly and then maintain the desired drug concentration. The drug- delivery system should deliver drug at a rate control by the necessarily of the body over a specified term of treatment. Market experts suggest that, There is a continuous growth in the market of drug delivery systems and will continue to grow at an impressive rate in future also. The novel drug delivery technologies enable to formulate the novel drug delivery devices by incorporating the drug molecules into new delivery systems, thus providing numerous therapeutic and commercial advantages. It was observed that NDDS market was segmented on the basis of route of administration, type of carrier and geographical region. In route of administration segment, injectable drug delivery system was observed as the largest market in 2015 followed by oral drug delivery system. Injectable drug delivery system comprises of several benefits over other dosage forms in cases such as unconsciousness, nausea, in emergency clinical episodes. The injectable administration route is the most common and efficient for delivery of active drug substances with poor bio-availability and the drugs with a narrow therapeutic index. On the basis of type of carrier, liposomes and microspheres collectively attribute the largest share in the market in terms of revenue (USD). The key factors assisting the growth of liposomes market are such as, biologically active materials encapsulated within liposomes are protected to varying extent from immediate dilution or degradation which assists drug carrier systems for the transport of drugs and other bioactive capsules to disease-affected organs

Market Competition Assessment:
The key players involved in the novel drug delivery systems (NDDS) market are 3M Company, Abbott Laboratories Ltd., Amgen Inc., AstraZeneca Plc, Bausch & Lomb, Baxter International Inc., Bayer AG, Boehringer Ingelheim, Boston Scientific, Bristolmyers Squibb, Celgene Corporation, Cephalon, Inc., Genentech Inc., Genzyme Corporation, Glaxosmithkline Plc, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi SA, and Teva Pharmaceutical Industries Ltd.

Key Market Movements:
  • North America is expected to lead the global novel drug delivery systems market due to high disposable income, increasing research and development activities associated with development of drug delivery systems, high adoption rate of novel technologies and supportive reimbursement policies.
  • Projected market entry of several products and technologies during 2016 to 2022 in global novel drug delivery systems market are expected to provide an exceptional growth to the market
  • Novel drug delivery systems market is expected to intensify the market competition, ignition of price wars, and drive emphasis towards geographical expansion and penetration strategies to sustain in the competition
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M Company
  • Amgen Inc.
  • Bayer AG
  • Celgene Corporation
  • Genzyme Corporation
  • Johnson & Johnson
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 Usp and Key Offerings
1.2 Research Methodology

Chapter 2 Executive Summary
2.1 Novel Drug Delivery Systems Market, by Route of Administration Type, 2016 - 2022 (USD Million)
2.2 Novel Drug Delivery Systems Market Share, by Carrier Type, 2022 (Value %)
2.3 Novel Drug Delivery Systems Market Share, by Geography, 2022 (Value %)

Chapter 3 Novel Drug Delivery Systems: Market Dynamics and Outlook
3.1 Introduction and Key Statistics
3.2 Novel Drug Delivery System: Current and Future Trends
3.3 Market Inclination Insights
3.4 Major Commercial Events
3.5 Market Dynamics
3.5.1 Drivers
3.5.2 Challenges
3.5.3 Opportunities
3.6 Porter's Five Forces Model
3.7 Attractive Investment Proposition
3.8 Market Positioning of Key Manufacturers

Chapter 4 Global Novel Drug Delivery Systems Market, by Route of Administration Type
4.1 Preface
4.2 Oral Drug Delivery Systems
4.3 Injectable Drug Delivery Systems
4.4 Pulmonary Drug Delivery Systems
4.5 Transdermal Drug Delivery Systems
4.6 Other Drug Delivery Systems

Chapter 5 Global Novel Drug Delivery System Market, by Carrier Type
5.1 Preface
5.2 Liposomes
5.3 Nanoparticles
5.4 Microspheres
5.5 Monoclonal Antibodies
5.6 Others (Niosomes and Resealed Erythrocytes as Drug Carriers)

Chapter 6 Global Novel Drug Delivery System Market, by Geography
6.1 Preface
6.2 North America
6.2.1 Us
6.3.2 Canada
6.3 Europe
6.3.1 U.K
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia Pacific
6.4.1 Japan
6.4.2 China
6.4.3 Rest of Asia Pacific
6.5 Latin America
6.6 Middle East and Africa

Chapter 7 Company Profiles
7.1 3M Company
7.2 Abbott Laboratories Ltd
7.3 Amgen Inc
7.4 Astrazeneca Plc
7.5 Bayer Ag
7.6 Boehringer Ingelheim
7.7 Celgene Corporation
7.8 Genentech Inc
7.9 Genzyme Corporation
7.10 Glaxosmithkline Plc
7.11 Merck & Co
7.12 Johnson & Johnson
7.13 Novartis Ag
7.14 Pfizer Inc
7.15 Roche Holding Ag
7.16 Sanofi Sa
7.17 Others

List of Figures
Figure 1 Novel Drug Delivery Systems Market, by Route of Administration Type, 2016 - 2022 (USD Million)
Figure 2 Novel Drug Delivery Systems Market, by Carrier Type, 2016 - 2022 (USD Million)
Figure 3 Global Novel Drug Delivery Systems Market Share, by Geography, 2022 (Value %)
Figure 4 Porter's Five Forces Model: Global Novel Drug Delivery System Market
Figure 5 Attractive Investment Proposition:Global Novel Drug Delivery Systemsmarket, 2015
Figure 6 Global Oral Drug Delivery Systems Market, 2013 - 2022 (USD Mn)
Figure 7 Global Injectable Drug Delivery Systems Market, 2013 - 2022 (USD Mn)
Figure 8 Global Pulmonary Drug Delivery Systems Market, 2013 - 2022 (USD Mn)
Figure 9 Global Transdermal Drug Delivery Systems Market, 2013 - 2022 (USD Mn)
Figure 10 Global Other Drug Delivery Systems Market, 2013 - 2022 (USD Mn)
Figure 11 Global Liposomes Market, 2013 - 2022 (USD Mn)
Figure 12 Global Nanoparticles Market, 2013 - 2022 (USD Mn)
Figure 13 Global Microspheres Market, 2013 - 2022 (USD Mn)
Figure 14 Global Monoclonal Antibodies Market, 2013 - 2022 (USD Mn)
Figure 15 Global Others Market, 2013 - 2022 (USD Mn)
Figure 16 North America Novel Drug Delivery Systems Market, 2013 - 2022 (USD Mn)
Figure 17 Europe Novel Drug Delivery Systems Market, 2015 - 2022 (USD Mn)
Figure 18 Latin America Novel Drug Delivery Systems Market, 2013 - 2022 (USD Mn)
Figure 19 Latin America Novel Drug Delivery Systems Market, 2013 - 2022 (USD Mn)
Figure 20 Middle East and Africa Novel Drug Delivery Systems Market, 2015 - 2022 (USD Mn)

List of Tables
Table 1 Global Novel Drug Delivery Systems Market, by Route of Administration Type, 2013 - 2022 (USD Mn)
Table 2 Global Novel Drug Delivery Systems Market, by Type of Carrier, 2013 - 2022 (USD Mn)
Table 3 Global Novel Drug Delivery Systems Market, by Geography, 2016 - 2022 (USD Mn)
Table 4 North America Novel Drug Delivery Systems Market, by Country, 2016 - 2022 (USD Mn)
Table 5 Europe Novel Drug Delivery Systems Market, by Country, 2016 - 2022 (USD Mn)
Table 6 Asia Pacific Novel Drug Delivery System Market, by Country, 2016 - 2022 (USD Mn)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3M Company
  • Abbott Laboratories Ltd.
  • Amgen Inc.
  • Astrazeneca Plc
  • Bayer AG
  • Boehringer Ingelheim
  • Celgene Corporation
  • Genentech Inc.
  • Genzyme Corporation
  • Glaxosmithkline Plc
  • Merck & Co.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi SA
  • Others
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll